Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-05

Clinical Trial Update: Dosing of Ketorolac in the Emergency Department [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating dosing of ketorolac for acute pain in the emergency department was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Acute Pain | Phase 4 | Status: TERMINATED | Results posted: 2024-11-05